Templated Open Flocs of Nanorods for Enhanced Pulmonary Delivery with Pressurized Metered Dose Inhalers
- 232 Downloads
A novel concept is presented for the formation of stable suspensions composed of low density flocs of high aspect ratio drug particles in hydrofluoroalkane (HFA) propellants, and for subdividing (templating) the flocs with aerosolized HFA droplets to achieve high fine particle fractions with a pressurized metered dose inhaler.
Bovine serum albumin (BSA) nanorods, produced by thin film freezing (TFF), were added to HFA to form a suspension. Particle properties were analyzed with an Anderson cascade impactor (ACI), static and dynamic light scattering and optical microscopy.
The space filling flocs in HFA were stable against settling for one year. The pMDI produced high fine particle fractions (38–47%) with an emitted dose of 0.7 mg/actuation. The atomized HFA droplets break apart, that is template, the highly open flocs. Upon evaporation of HFA, capillary forces shrink the templated flocs to produce porous particles with optimal aerodynamic diameters for deep lung delivery.
Open flocs composed of nanorods, stable against settling, may be templated during actuation with a pMDI to produce optimal aerodynamic diameters and high fine particle fractions. This concept is applicable to a wide variety of drugs without the need for surfactants or cosolvents to stabilize the primary particles.
KEY WORDSbovine serum albumin floc nanorod pressurized metered dose inhaler suspension stability
- 3.S. White, D. B. Bennett, S. Cheu, P. W. Conley, D. B. Guzek, S. Gray, J. Howard, R. Malcolmson, J. M. Parker, P. Roberts, N. Sadrzadeh, J. D. Schumacher, S. Seshadri, G. W. Sluggett, C. L. Stevenson, and N. J. Harper. EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin. Diabetes Technol. Ther. 7:896–906 (2005) doi:10.1089/dia.2005.7.896.PubMedCrossRefGoogle Scholar
- 14.K. A. Johnson. Interfacial phenomena and phase behavior in metered dose inhaler formulations. In A. J. Hickey (ed.), Inhalation Aerosols: Physical and Biological Basis for Therapy, Vol. 221. Lung Biology in Health and Disease, 2007.Google Scholar
- 15.E. A. Quinn, R. T. Forbes, A. C. Williams, M. J. Oliver, L. McKenzie, and T. S. Purewal. Protein conformational stability in the hydrofluoroalkane propellants tetrafluoroethane and heptafluoropropane analyzed by Fourier transform Raman spectroscopy. Int. J. Pharm. 186:31–41 (1999) doi:10.1016/S0378-5173(99)00135-0.PubMedCrossRefGoogle Scholar
- 16.M. J. Oliver, L. McKenzie, W. D. Graffiths, G. R. Morgan, and N. O’Kelly. Initial assessment of a protein formulated in pressurized MDIS for pulmonary delivery. In RDD VII, 2000.Google Scholar
- 17.C. Benfait. Kos reports achievement of new research and development milestones. Kos Press Release (2004).Google Scholar
- 23.Y.-F. Maa, and H. R. Costantino. Spray freeze-drying of biopharmaceuticals: applications and stability considerations. In H. R. Costantino, and M. J. Pikal (eds.), Biotechnology: Pharmaceutical Aspects. 2. Lyophilization of Biopharmaceuticals, Vol. 2, American Association of Pharmaceutical Scientists, Arlington, 2004, pp. 519–561.Google Scholar
- 26.J. D. Engstrom, D. T. Simpson, C. Cloonan, E. Lai, R. O. Williams III, G. B. Kitto, and K. P. Johnston. Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen. Eur. J. Pharm. Biopharm. 65:163–174 (2007) doi:10.1016/j.ejpb.2006.08.002.PubMedCrossRefGoogle Scholar
- 28.Z. Yu, T. L. Rogers, J. Hu, K. P. Johnston, and R. O. Williams III. Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm. 54:221–228 (2002) doi:10.1016/S0939-6411(02)00050-4.PubMedCrossRefGoogle Scholar
- 34.Y.-H. Liao, M. B. Brown, S. A. Jones, T. Nazir, and G. P. Martin. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers. Int. J. Pharm. 304:29–39 (2005) doi:10.1016/j.ijpharm.2005.07.013.PubMedCrossRefGoogle Scholar
- 39.L. Wu, R. P. S. Peguin, P. Selvam, U. Chokshi, and S. R. P. da Rocha. Molecular scale behavior in alternative propellant-based inhaler formulations. In A. J. Hickey (ed), Inhalation Aerosols: Physical and biological basis for therapy, Vol. 221. Lung Biology in Health and Disease, 2007.Google Scholar
- 42.J. Tam, J. T. McConville, R. O. Williams III, and K. P. Johnston. Amorphous cyclosporin A nanodispersions for enhanced pulmonary deposition and dissolution. J. Pharm. Sci. in press (2008) doi:10.1002/jps.21367.
- 45.P. C. Hiemenz and R. Rajagopalan. Principles of colloid and surface chemistry, Marcel Dekker, New York, 1997.Google Scholar
- 48.R. G. Larson. The structure and rheology of complex fluids. Oxford University Press, New York, 1999.Google Scholar
- 56.S. L. Nail, S. Jiang, S. Chongprasert, and S. A. Knopp. Fundamentals of freeze-drying. In S. L. Nailand, and M. J. Akers (eds.), Pharmaceutical Biotechnology. 14. Development and Manufacture of Protein Pharmaceuticals, Vol. 14, Kluwer, New York, 2002, pp. 281–360.Google Scholar
- 57.S. D. Webb, J. L. Cleland, J. F. Carpenter, and T. W. Randolph. A new mechanism for decreasing aggregation of recombinant human interferon-g by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. J. Pharm. Sci. 91:543–558 (2002) doi:10.1002/jps.10033.PubMedCrossRefGoogle Scholar
- 58.J. F. Carpenter, B. S. Chang, W. Garzon-Rodriguez, and T. W. Randolph. Rational design of stable lyophilized protein formulations: theory and practice. In J. F. Carpenter, and M. C. Manning (eds.), Pharmaceutical Biotechnology. 13. Rational Design of Stable Protein Formulations, Vol. 13, Kluwer, New York, 2002, pp. 109–133.Google Scholar
- 61.W. H. Finlay. The mechanics of inhaled pharmaceutical aerosols, Academic,New York, 2001.Google Scholar
- 62.A. Sihvola. Electromagnetic mixing formulas and applications, Institute of Electrical Engineers, London, 1999.Google Scholar
- 63.W. B. Russel, D. A. Saville, and W. R. Schowalter. Colloidal dispersions, Cambridge University Press, Cambridge, 1989.Google Scholar
- 65.M. A. Bevan. Effect of adsorbed polymer on the interparticle potential, chemical engineering. Carnegie Mellon University, Pittsburgh, 1999.Google Scholar
- 69.D. R. Ulrich. Chemical processing of ceramics. Chem. Eng. News. 68:28–40 (1990).Google Scholar
- 70.H. D. C. Smyth, A. J. Hickey, and R. M. Evans. Aerosol generation from propellant-driven metered dose inhalers. In J. Hickey Anthony (ed), Inhalation Aerosols: Physical and Biological Basis for Therapy, Vol. 221, Lung biology in health and disease, 2007, pp. 399–416.Google Scholar
- 72.T. L. Rogers, A. C. Nelsen, J. Hu, J. N. Brown, M. Sarkari, T. J. Young, K. P. Johnston, and R. O. Williams III. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur. J. Pharm. Biopharm. 54:271–280 (2002) doi:10.1016/S0939-6411(02)00063-2.PubMedCrossRefGoogle Scholar
- 73.T. L. Rogers, K. A. Overhoff, P. Shah, P. Santiago, M. J. Yacaman, K. P. Johnston, and R. O. Williams III. Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process. Eur. J. Pharm. Biopharm. 55:161–72 (2003) doi:10.1016/S0939-6411(02)00193-5.PubMedCrossRefGoogle Scholar
- 74.J. Israelachvili. Intermolecular and surface forces. Academic, San Diego, 1992.Google Scholar